340B Program Improvement and Integrity Act of 2007

Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of children's hospitals to the 340B program, physician-administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement and Integrity Act of 2007 (S. 1376/H.R. 2606), Proposed guidelines from the Health Resources and Services Administration (HRSA) addressing the definition of "patient" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA).

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Veterans Affairs, Dept of (VA)

Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of children's hospitals to the 340B program, physician-administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement and Integrity Act of 2007 (S. 1376/H.R. 2606), Proposed guidelines from the Health Resources and Services Administration (HRSA) addressing the definition of "patient" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA).

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Veterans Affairs, Dept of (VA)

Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of children's hospitals to the 340B program, physician-administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement and Integrity Act of 2007 (S. 1376/H.R. 2606), Proposed guidelines from the Health Resources and Services Administration (HRSA) addressing the definition of "patient" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA).

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Veterans Affairs, Dept of (VA)

Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of children's hospitals to the 340B program, physician-administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement and Integrity Act of 2007 (S. 1376/H.R. 2606), Proposed guidelines from the Health Resources and Services Administration (HRSA) addressing the definition of "patient" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA).

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Veterans Affairs, Dept of (VA)

Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of children's hospitals to the 340B program, physician-administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement and Integrity Act of 2007 (S. 1376/H.R. 2606), Proposed guidelines from the Health Resources and Services Administration (HRSA) addressing the definition of "patient" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA).

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Veterans Affairs, Dept of (VA)

Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of children's hospitals to the 340B program, physician-administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement and Integrity Act of 2007 (S. 1376/H.R. 2606), Proposed guidelines from the Health Resources and Services Administration (HRSA) addressing the definition of "patient" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA).

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Veterans Affairs, Dept of (VA)

Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of children's hospitals to the 340B program, physician-administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement and Integrity Act of 2007 (S. 1376/H.R. 2606), Proposed guidelines from the Health Resources and Services Administration (HRSA) addressing the definition of "patient" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA).

Client expense: Not reported · Firm income: $10,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Veterans Affairs, Dept of (VA)

Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of children's hospitals to the 340B program, physician-administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement and Integrity Act of 2007 (S. 1376/H.R. 2606), Proposed guidelines from the Health Resources and Services Administration (HRSA) addressing the definition of "patient" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA).

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Veterans Affairs, Dept of (VA)

Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of children's hospitals to the 340B program, physician-administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement and Integrity Act of 2007 (S. 1376/H.R. 2606), Proposed guidelines from the Health Resources and Services Administration (HRSA) addressing the definition of "patient" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA).

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Veterans Affairs, Dept of (VA)

Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of children's hospitals to the 340B program, physician-administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement and Integrity Act of 2007 (S. 1376/H.R. 2606), Proposed guidelines from the Health Resources and Services Administration (HRSA) addressing the definition of "patient" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA).

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Veterans Affairs, Dept of (VA)

Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of children's hospitals to the 340B program, physician-administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement and Integrity Act of 2007 (S. 1376/H.R. 2606), Proposed guidelines from the Health Resources and Services Administration (HRSA) addressing the definition of "patient" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA).

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Veterans Affairs, Dept of (VA)

H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H. R. 3162, Children's Health and Medicare Protection Act of 2007 H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H. R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions Comparative Effectiveness 2008 Medicare Bill H.R. 1424, Emergency Economic Stabilization Act of 2008

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE

H.R. 2606 (S. 1376)- 340B Program Improvement and Integrity Act of 2007

Client expense: Not reported · Firm income: $15,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Discounted Drug Prices for 340B Hospitals: Section 340B of the Public Health Services Act (HR 2606/S 1376).

Client expense: $41,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

HR 2606 and S 1376. Extending 340B Drug Pricing to Inpatient Setting in DSH Hospitals and improving program integrity. Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs

Client expense: $161,917 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE

Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of children's hospitals to the 340B program, physician-administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement and Integrity Act of 2007 (S. 1376/H.R. 2606), Proposed guidelines from the Health Resources and Services Administration (HRSA) addressing the definition of "patient" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA).

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Veterans Affairs, Dept of (VA)

Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of children's hospitals to the 340B program, physician-administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement and Integrity Act of 2007 (S. 1376/H.R. 2606), Proposed guidelines from the Health Resources and Services Administration (HRSA) addressing the definition of "patient" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA).

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Veterans Affairs, Dept of (VA)

HR 2606, S 1376 340B Program Improvement & Integrity Act. Any language extending 340B drug discounts to inpatient setting.

Client expense: $125,005 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 2606 and S 1376: Extending 340B Drug Pricing to Inpatient Drugs and improving program integrity Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs

Client expense: $181,501 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

HR 2606 and S 1376: Extending 340B Drug Pricing to Inpatient Drugs and improving program integrity Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs

Client expense: $181,501 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of children's hospitals to the 340B program, physician-administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement and Integrity Act of 2007 (S. 1376/H.R. 2606), Proposed guidelines from the Health Resources and Services Administration (HRSA) addressing the definition of "patient" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA).

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Veterans Affairs, Dept of (VA)

Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of children's hospitals to the 340B program, physician-administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement and Integrity Act of 2007 (S. 1376/H.R. 2606), Proposed guidelines from the Health Resources and Services Administration (HRSA) addressing the definition of "patient" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA).

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Veterans Affairs, Dept of (VA)

HR 2606 and S 1376. Extending 340B Drug Pricing to Inpatient Setting in DSH Hospitals and improving program integrity. Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs

Client expense: $224,795 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE

H.R. 3610, Foreign Facility FDA Inspection User Fees; H.R. 1585, National Defense Authorization (portions relating to Tricare); protecting patient access in S. 877, Controlling the Abuse of Prescriptions Act; S. 2029, Physician Payments Sunshine Act of 2007; S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion

Client expense: $300,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE

H.R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R. 3162, Children's Health and Medicare Protection Act of 2007 H.R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions H.R. 5480 Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B Drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provision Comparative Effectiveness S. 2099 "Preserving Access to Laboratory Services Act of 2007" Repeal of Competitive bidding demo ESRD "bundling issues" and ESRD drug reimbursement issues Medicare prescription drug benefit H.R. 1321 "Medicare Advanced Laboratory Diagnostic Act of 2007" S. 691/H.R. 1193 The Kidney Care Quality and Education Act CPT Coding decisions and HCPCS coding decisions Reimbursement for Part B Drugs administered in hospital out patient departments, dialysis centers and physician officers Physicians fee schedule payment rates for lab tests. Medicaid rebates H.R. 2184, The Enhanced health Care Value for All Act H.R. 6331 "Medicare Improvements for Patients and Providers Act of 2008" S. 3101, "Medicare Improvements for Patients and Providers Act of 2008" MIPPA Technical Connections H.R. 1472 Emergency Economic Stabilization Act of 2008

Client expense: $658,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR2606/S1376: 340B PROGRAM IMPROVEMENT AND INTEGRITY ACT OF 2007; 340B DRUG EXPANSION HR3162: CHILDREN'S HEALTH AND MEDICARE PROTECTION ACT OF 2007; ALL PROVISIONS OF BILL HR4/S3: MEDICARE PRESCRIPTION DRUG PRICE NEGOTIATION ACT: MEDICARE "NON-INTERFERENCE" PROVISIONS HR5480: MEDICARE FUNDING WARNING RESPONSE ACT OF 2008; ALL PROVISIONS S2029: PHYSICIAN PAYMENT SUNSHINE ACT OF 2007; ALL PROVISIONS OF BILL S2662: MEDICARE FUNDING WARNING RESPONSE ACT OF 2008; ALL PROVISIONS OF BILL S3408: COMPARATIVE EFFECTIVENESS RESEARCH ACT OF 2008; ALL PROVISIONS OF BILL HR6331/S3101: MEDICARE IMPROVEMENTS FOR PATIENTS AND PROVIDERS ACT OF 2008; ALL PROVISIONS OF BILL HR1424: EMERGENCY ECONOMIC STABILIZATION ACT OF 2008; ALL PROVISIONS OF BILL

Client expense: $500,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 242/H.R. 380- Pharmaceutical Market Access and Drug Safety Act of 2007- entire bill. S. 586/H.R. 1968- Community Health Workers Act of 2007- entire bill. S. 980/H.R. 6353- Online Pharmacy Consumer Protection Act of 2007- entire bill. S. 1240/H.R. 464- Compassionate Assistance for Rape Emergencies Act of 2007- entire bill. S. 1375- Mom's Opportunity to Access Health, Education, Research, and Support for Postpartum Depression Act/MOTHERS Act- entire bill. S. 1376/H.R. 2606- 340B Program Improvement and Integrity Act of 2007- entire bill. S. 2347/H.R. 4054- Prevention Through Affordable Access Act- entire bill. S. 1555/H.R. 2596- Access to Birth Control Act- entire bill. S.1800/H.R. 2064- Compassionate Care for Servicewomen Act- entire bill. S. 2731/ H.R. 5501- The Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008- provisions related to family planning, sex education, abstinence, and abortion. H.R. 20- Melanie Blocker-Stokes Postpartum Depression Research and Care Act- entire bill. H.R. 1424- Paul Wellstone Mental Health and Addiction Equity Act of 2007- potential provision related to abortion and possible provision related to nominal drug pricing. H.R. 3014- The Health Equity and Accountability Act of 2007- entire bill. H.Res. 1131- Recognizing that the Centers for Disease Control and Prevention observes the month of April as National STD Awareness Month and urging the House of Representatives to focus greater attention on activities related to the prevention of STDs and screening and treatment for STDs- entire resolution. H.R. 6357- Protecting Records, Optimizing Treatment, and Easing Communication Through Health Care Technology Act- provisions on health care technology transition. H.R. 6100/S. 3040- Kid-Safe Chemicals Act of 2008- entire bill. H.R. 6906- H.I.V. Education and Prevention Act of 2008- entire bill. H.R. 6680- Community AIDS and Hepatitis Prevention Act- entire bill. H.R. 6358- Stop Abuse in Residential Treatment Programs Act of 2008- provision related to contraceptive access. H.R. 1237/S. 2510- Cytology Proficiency Improvement Act of 2008- entire bill. S. 20/ H.R. 7310- Protecting Patients and Health Care Act- entire bill. H.R. 7296- Midnight Rule Act- provision relating to the Department of Health and Human Services physician conscience regulation. S. 3297- Advancing Americas Priorities Act- provision related to nominal drug pricing. H.Con.Res. 400- Expressing the support of the Congress regarding the need to ensure health care for women and health care for all in national health care reform- entire resolution.

Client expense: $121,667 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 1375- Mom's Opportunity to Access Health, Education, Research, and Support for Postpartum Depression Act/MOTHERS Act- entire bill. S. 1376/H.R. 2606- 340B Program Improvement and Integrity Act of 2007- entire bill. S. 2347/H.R. 4054- Prevention Through Affordable Access Act- entire bill. S. 1555/H.R. 2596- Access to Birth Control Act- entire bill. S. 2731/ H.R. 5501- The Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008- provisions related to family planning, sex education, abstinence, and abortion. H.R. 20- Melanie Blocker-Stokes Postpartum Depression Research and Care Act- entire bill. H.R. 1424- Paul Wellstone Mental Health and Addiction Equity Act of 2007- potential provision related to abortion and possible provision related to nominal drug pricing. H.R. 6100/S. 3040- Kid-Safe Chemicals Act of 2008- entire bill. H.R. 1237/S. 2510- Cytology Proficiency Improvement Act of 2008- entire bill. S. 20/ H.R. 7310- Protecting Patients and Health Care Act- entire bill. H.R. 7296- Midnight Rule Act- provision relating to the Department of Health and Human Services physician conscience regulation. S. 3297- Advancing Americas Priorities Act- provision related to nominal drug pricing. H.Res.1131 - Recognizing that the Centers for Disease Control and Prevention observes the month of April as National STD Awareness Month and urging the House of Representatives to focus greater attention on activities related to the prevention of STDs and screening and treatment for STDs- entire resolution. H.Con.Res. 400- Expressing the support of the Congress regarding the need to ensure health care for women and health care for all in national health care reform- entire bill.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of children's hospitals to the 340B program, physician-administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement and Integrity Act of 2007 (S. 1376/H.R. 2606), Proposed guidelines from the Health Resources and Services Administration (HRSA) addressing the definition of "patient" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA).

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Veterans Affairs, Dept of (VA)

H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H. R. 3162, Children's Health and Medicare Protection Act of 2007 H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H. R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H.R. 1424, Emergency Economic Stabilization Act of 2008

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H. R. 3162, Children's Health and Medicare Protection Act of 2007 H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H. R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions Comparative Effectiveness 2008 Medicare Bill H.R. 1424, Emergency Economic Stabilization Act of 2008

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE

H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 3162, Children's Health and Medicare Protection Act of 2007 H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions H. R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions 2008 Medicare Bill Comparative Effectiveness

Client expense: Not reported · Firm income: $50,000

Government targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 3162, Children's Health and Medicare Protection Act of 2007 H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions H. R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions Comparative Effectiveness Lab demonstration issue H.R. 1424, Emergency Economic Stabilization Act of 2008 ESRD "bundling issues" and ESRD drug reimbursement issues MIPPA Technical Corrections

Client expense: Not reported · Firm income: $100,000

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

340B Program, S.1376 and H.R.2606; Hospital Outpatient Pharmacy Departments (HOPDs); Legislation increasing ASC Payments - H.R.1823 and S.225; S.1693 the Wired for Health Care Quality Act; S.334 the Healthy Americans Act; H.R. 2580 medical liability reform legislation; Mental Health Parity legislation - H.R.1424 (provision limiting physician self referral; and health related provisions in the Iraq War Supplemental - H.R.2206 - dealing with limiting physician self referral.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.3656, H.R. 7241 - Preserving Access to Healthcare (PATH) Act S. 2499 - Medicare, Medicaid, and SCHIP Extension Act of 2007 H.R. 2606 - The 340B Program Improvement and Integrity Act of 2007 S. 1376 - The 340B Program Improvement and Integrity Act of 2007 H.R. 3453 The Community Clinical Laboratory Fairness in Competition Act of 2007 HR 5613 - Protecting the Medicaid Safety Net Act of 2007 S.543 - Preserving Patient Access to Inpatient Rehabilitation Hospitals Act of 2007 S. 2099 - the Preserving Access to Laboratory Services Act of 2007 H.R. 6331/S.3101 - Medicare Improvements for Patients and Providers Act of 2008

Client expense: $110,000 · Firm income: Not reported

Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

HR 2606/S1376 (340B Program Integrity & Improvement Act), HR 6089/S 2773 (Pediatric Research Consortia Act), HR 6057, Medicaid Rule Moratorium, S 2932 (Poison Control Reauthorization), Labor/HHS/Education Appropriations (Children's Hospitals Graduate Medical Education), TARP II (bond insurance for tax exempt bonds)

Client expense: $113,875 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 5480, Medicare Funding Warning Response Act of 2008 HR 2606, 340B Program Improvement and Integrity Act of 2007, 340 drug price expansion HR 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions HR 3162, Children's Health and Medicare Protection Act of 2007 S 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S 2029, Physician Payments Sunshine Act of 2007

Client expense: $580,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R.5480, Medicare Funding Warning Response Act of 2008 H.R.2602, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R.4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions S.1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S.2029, Physician Payments Sunshine Act of 2007 S.2662, Medicare Funding Warning Response Act of 2007 H.R.1424, Emergency Economic Stabalization Act of 2008 H.R.3162, Childrens Health and Medicare Protection Act of 2007 SCHIP (Senate), Medicare cuts to finance SCHIP expansion S. 3101, Medicare Improvements for Patients and Providers Act of 2008

Client expense: $440,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Monitor S. 1695, Biologics Price Competition and Innovation Act of 2007, to ensure that it does not apply to plasma proteins. S. 1376 and H.R. 2606, 340B Program Improvement and Integrity Act of 2007; H.R. 2860 - Health Care Access and Rural Equity (H-CARE) Act of 2007: Ensure bills do not expand this program at the expense of patient access to plasma protein therapies. Monitor H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008. Maintain status quo for the Medicaid rebate as applied to plasma protein therapies.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2606 (S. 1376)- 340B Program Improvement and Integrity Act of 2007

Client expense: Not reported · Firm income: $15,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 - Our interest centers on eliminating the cut to Medicare rates to Physicians and Wage Index, Rural Floor and other rural issues contained in the bill. H.R. 4105, Medicare Recovery Audit Contractor Program Moratorium Act - Our interest is being sure that these RAC audits have appropriate oversight and regulation. S. 142, A bill to amend title XXI of the Social Security Act to allow qualifying States to use all or any portion of their allotments under the State Children's Health Insurance Program for certain Medicaid expenditures. - Our interest since we have a Children's Hospital is a robust renewal of SCHIP. S. 2460, A bill to extend by one year the moratorium on implementation of a rule relating to the Federal-State financial partnership under Medicaid and the State Children's Health Insurance Program.- Our interest since we have a Children's Hospital is a robust renewal of SCHIP. H.R. 117, To amend title XVIII of the Social Security Act to provide for a permanent hold harmless provision for sole community hospitals under the Medicare prospective payment system for covered outpatient department services. - Our interest since we are a Sole Community Hospital (SCH) is in securing this provision. S. 1376, A bill to amend the Public Health Service Act to revise and expand the drug discount program under section 340B of such Act to improve the provision of discounts on drug purchases for certain safety net providers. - Our interest since we've just become an SCH is in participating in the 340B program. H.R. 5613, Protecting the Medicaid Safety Act of 2008. - Our interest is in support for medical education and better Medicare and Medicaid reimbursement. S. 3656, Preserving Access to Healthcare (PATH) Act of 2008. - Our interest is to delay a two-year phase-out of capital IME payments for teaching hospitals.

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2606, S. 1376, the 340B Program Improvement & Integrity Act of 2007

Client expense: $200,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 6444 and S. 334, Healthy Americans Act H.R. 3333, S. 1576, Minority Health Improvment and Health Disparity Elimination Act H.R. 2606, S. 1376, the 340B Program Improvement & Integrity Act of 2007 Economic Relief Package in the House and Senate

Client expense: $200,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Discounted Drug Prices for 340B Hospitals: Section 340B of the Public Health Services Act (HR 2606/S 1376).

Client expense: $62,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE